HOUSTON--(BUSINESS WIRE)--Sept. 14, 2006--Stem Cell Innovations (OTCBB:SCLL), a cell biology company that has developed technology capable of creating a broad range of human cells from its patented, pluripotent stem cells, announced today that it has signed an agreement to supply PluriCells(TM) to researchers at Stanford University. Under the agreement, investigators at Stanford may receive the cells for use in their laboratories.
